Joel Jung

Joel Jung

Finansdirektör/CFO på RENALYTIX PLC

Förmögenhet: 5 115 $ per 2026-05-31

68 år
Health Technology
Health Services
Consumer Services

Profil

Joel R.
Jung
's current job is Chief Financial Officer at Renalytix Plc.
Former jobs include Treasurer & Vice President at Chiron Corp.
from 2003 to 2006, Vice President-Finance at Applera Corp.
from 2006 to 2008, Chief Financial Officer at AgraQuest, Inc. from 2010 to 2012, Chief Financial Officer & Treasurer at Celera Corp.
in 2009, Chief Financial Officer at Myriad Women's Health, Inc. from 2016 to 2018, Chief Financial Officer & Vice President-Finance at Bionano Genomics, Inc. from 2014 to 2016, Vice President-Finance at Bayer CropScience LP from 2012 to 2013, Vice President- Finance at Applied Biosystems, Inc. from 2006 to 2008, and Chief Financial Officer at uBiome, Inc. in 2019.
Mr. Jung's education includes an undergraduate degree from Purdue University and an MBA from Haas School of Business.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-02-11 210 855 ( 0,05 % ) 5 115 $ 2026-05-31

Aktiva positioner av Joel Jung

FöretagPositionStart
RENALYTIX PLC Finansdirektör/CFO 2024-05-28

Tidigare kända positioner av Joel Jung

FöretagPositionSlut
MINERVA SURGICAL, INC. Finansdirektör/CFO 2024-02-01
Finansdirektör/CFO 2019-06-01
Finansdirektör/CFO 2018-09-01
BIONANO GENOMICS, INC. Finansdirektör/CFO 2016-06-01
Finansdirektör/CFO 2013-07-01
Se detaljerna i Joel Jungs erfarenhet

Joel Jungs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

74

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Health Technology

Health Technology

Process Industries

Health Services

Health Technology

Health Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Technology Services

- 40% : De bästa verktygen för abonnenter som vill hitta morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU